Sg Americas Securities, LLC / REGN
Sg Americas Securities, LLC’s Regeneron Pharmaceuticals Position
Does Sg Americas Securities, LLC own Regeneron Pharmaceuticals (REGN)? Yes — 158.3K shares worth $122M (+0.13% of its 13F portfolio) as of Q1 2026, up from 131.1K shares the prior filed quarter.
Position Value
$122M
Q1 2026
Shares
158.3K
% of Portfolio
+0.13%
Quarters Held
29
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 158.3K | $122M | +0.13% |
| Q4 2025 | 131.1K | $101M | +0.13% |
| Q3 2025 | 12.4K | $7M | +0.02% |
| Q2 2025 | 16.0K | $8M | +0.03% |
| Q1 2025 | 64.1K | $41M | +0.13% |
| Q4 2024 | 1.9K | $1M | +0.01% |
| Q3 2024 | 23.4K | $25M | +0.09% |
| Q2 2024 | 40.4K | $42M | +0.25% |
| Q1 2024 | 10.5K | $10M | +0.05% |
| Q4 2023 | 7.3K | $6M | +0.06% |
| Q3 2023 | 24.1K | $20M | +0.23% |
| Q2 2023 | 44.2K | $32M | +0.24% |
| Q1 2023 | 27.1K | $22M | +0.26% |
| Q4 2022 | 22.7K | $16M | +0.20% |
| Q3 2022 | 12.3K | $8M | +0.10% |
| Q2 2022 | 7.1K | $4M | +0.04% |
| Q1 2022 | 8.3K | $6M | +0.04% |
| Q4 2021 | 9.9K | $6M | +0.03% |
| Q3 2021 | 3.0K | $2M | +0.01% |
| Q2 2021 | 20.3K | $11M | +0.05% |
| Q1 2021 | 13.2K | $6M | +0.03% |
| Q4 2020 | 18.1K | $9M | +0.05% |
| Q3 2020 | 25.0K | $14M | +0.09% |
| Q2 2020 | 17.0K | $11M | +0.09% |
| Q1 2020 | 13.5K | $7M | +0.06% |
| Q4 2019 | 11.1K | $4M | +0.04% |
| Q3 2019 | 45.3K | $13M | +0.10% |
| Q2 2019 | 91.3K | $29M | +0.20% |
| Q1 2019 | 26.9K | $11M | +0.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sg Americas Securities, LLC’s full portfolio or all institutional holders of REGN.